Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of α-Gal Glycolipids that Induce Anti-Gal/α-Gal Epitope Interaction
Anti-Gal is the most abundant antibody in humans, constituting 1% of immunoglobulins. Anti-Gal binds specifically α-gal epitopes (Galα1-3Galβ1-4GlcNAc-R). Immunogenicity of autologous tumor associated antigens (TAA) is greatly increased by manipulating tumor cells to express α-gal epitopes and bind...
Saved in:
| Main Author: | Uri Galili |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2011/134020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies
by: Grayson Hatfield, et al.
Published: (2023-12-01) -
Analysis of epitopes and structural responses in egg allergen Gal d 1 using bioinformatic tools and molecular dynamics simulation
by: Tao Wang, et al.
Published: (2025-01-01) -
System-Level Design, Modeling, and Verification of GALS Cyber-Physical Systems
by: Weiyi Zhang, et al.
Published: (2025-01-01) -
Opinion: Ecologists and entomologists wanted! An open invitation to alpha-gal syndrome research
by: Kate M. Barnett, et al.
Published: (2025-09-01) -
Precision Probing of O-GalNAc Glycosylation Using Bump-and-Hole Engineering
by: Abdul Zafar, et al.
Published: (2025-03-01)